At the highest dose, systolic blood pressure fell by an average of 14 mmHg, a meaningful drop from a heart-health perspective
Bottom Line While retatrutide remains an investigational treatment currently unavailable for commercial purchase, exploring established, approved weight management therapies with your doctor provides a safe and effective path forward
WHO Decision Recognizing Obesity as a Disease Treatable with GLP-1 Drugs Is Big Deal, says BU Endocrinologist New guidelines will help reduce stigma around weight management, Ivania Rizo says WHO Decision Recognizing Obesity as a Disease Treatable with GLP-1 Drugs Is Big Deal, says BU Endocrinologist New guidelines will help reduce stigma around weight management, Ivania Rizo says The World Health Organizations new guidelines recognizing obesity as a disease and suggesting that GLP-1 drugs be part of long-term treatment could have wide-ranging benefits, says Ivania Rizo, a Boston University endocrinologist whose research interests center on obesity, diabetes, and metabolic disorders
The chemical integrity of the peptide was perfectly preserved
(2016) The glutathione derivative GSHmonoethyl ester may enhance pheomelanin formation, International Journal of Molecular Sciences, [online]